packageLazertinib

lazertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lazertinib is a protein kinase inhibitor used to treat non-small-cell lung carcinoma. It is an authorised medicine in the European Union for this cancer indication.

Summary written by glm-5.3-flash from Wikidata Q105337288 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lazertinib
ATC codes:L01EB09
DrugBank:DB16216
PubChem CID:121269225
Wikidata:Q105337288
formula:C30H34N8O3
molar mass:554.655 g/mol (PubChem CID 121269225)
logP:3.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown